首页|血清miR-135b、LZST1表达水平与晚期非小细胞肺癌患者预后的相关性

血清miR-135b、LZST1表达水平与晚期非小细胞肺癌患者预后的相关性

扫码查看
目的 探究晚期非小细胞肺癌(NSCLC)患者血清微小RNA-135b(miR-135b)、亮氨酸拉链肿瘤抑制基因1(LZST1)表达水平及与其预后的相关性.方法 收集62例晚期NSCLC患者作为观察组.另外收集同时期94例良性肺部病变患者作为对照组.比较观察组与对照组血清miR-135b、LZST1表达水平差异,比较不同预后患者血清miR-135b、LZST1表达水平差异,分析晚期NSCLC患者血清miR-135b、LZST1表达水平与其预后的关系,miR-135b、LZST1对晚期NSCLC患者预后不良的预测价值.结果 两组性别、年龄、体质量指数比较差异不显著,P>0.05.观察组血清miR-135b表达水平高于对照组,LZST1低于对照组,差异有统计学意义(P<0.05).死亡患者血清miR-135b表达水平高于存活患者,LZST1水平低于对照组,差异有统计学意义(P<0.05).miR-135b与晚期NSCLC患者死亡呈显著正相关关系,LZST1与晚期NSCLC患者死亡呈负相关关系,miR-135b与LZST1表达呈负相关关系,P<0.05.计算约登指数,获取最大约登指数相对应的临界值.4.065为miR-135b预测晚期NSCLC患者死亡的阈值,灵敏度84.00%,特异度81.10%,0.670为LZST1预测晚期NSCLC患者死亡的阈值,灵敏度68.00%,特异度78.40%.miR-135b、LZST1以及两者联合的AUC面积分别为0.792、0.742以及0.850,两者联合的AUC面积最大,灵敏度为88.00%,特异度为70.30%,预测效能较好.结论 晚期NSCLC患者血清miR-135b表达水平异常升高,LZST1显著降低,miR-135b高表达、LZST1低表达与患者预后不良相关,miR-135b与LZST1呈负相关关系.miR-135b联合LZST1对晚期NSCLC患者死亡的预测效能较高.
Correlation of Serum miR-135b and LZST1 Expression Levels and Prognosis in Patients with Advanced Non-small Cell Lung Cancer
Objective To investigate the expression levels of serum micrornA-135b(miR-135b)and leucine zipline tumor suppressor gene 1(LZST1)in patients with advanced non-small cell lung cancer(NSCLC)and their correlation with prog-nosis.Methods 62 patients with advanced NSCLC were collected as the observation group.In addition,94 patients with benign pulmonary lesions were collected as control group.Compare the expression levels of serum miR-135b and LZST1 between the ob-servation group and the control group,compared the expression levels of serum miR-135b and LZST1 in patients with different prognosis,and analyze the relationship between the expression levels of serum miR-135b and LZST1 in patients with advanced NSCLC and their prognosis.Prognostic value of miR-135b and LZST1 in patients with advanced NSCLC.Results There were no significant differences in gender,age and body mass index between the 2 groups(P>0.05).The expression level of serum miR-135b in the observation group was higher than that in the control group,and LZST1 was lower than that in the control group,the difference was statistically significant(P<0.05).The serum miR-135b expression level of dead patients was higher than that of surviving patients,and the LZST1 level was lower than that of the control group,with statistical significance(P<0.05).There was a significant positive correlation between miR-135b and death in advanced NSCLC patients,a negative correlation between LZST1 and death in advanced NSCLC patients,and a negative correlation between miR-135b and LZST1 expression(P<0.05).Calcu-late the Jorden index and obtain the critical value corresponding to the maximum approximate index.4.065 was the threshold for miR-135b to predict death in patients with advanced NSCLC,with a sensitivity of 84.00%and a specificity of 81.10%;0.670 was the threshold for LZST1 to predict death in patients with advanced NSCLC,with a sensitivity of 68.00%and a specificity of 78.40%.The AUC area of miR-135b,LZST1 and their combination was 0.792,0.742 and 0.850,respectively.The AUC area of Mir-135b,LZST1 and their combination was the largest,the sensitivity was 88.00%,and the specificity was 70.30%,indicating good prediction efficiency.Conclusion The expression level of serum miR-135b is abnormally elevated and LZST1 is significant-ly decreased in patients with advanced NSCLC.High expression of miR-135b and low expression of LZST1 are correlated with poor prognosis of patients,and miR-135b is negatively correlated with LZST1.miR-135b combined with LZST1 has high predictive effi-cacy in patients with advanced NSCLC.

Late stageNSCLCmiR-135bLZST1Prognosis

冀会娟、李海斌、刘瑶、史江

展开 >

456300 河南中医药大学第五临床医学院,郑州人民医院

晚期 NSCLC miR-135b LZST1 预后

二0一九年度河南省医学科技攻关计划项目

LH-GJ20190036

2024

实用癌症杂志
江西省肿瘤医院 江西省肿瘤研究所

实用癌症杂志

影响因子:1.241
ISSN:1001-5930
年,卷(期):2024.39(10)